Skip to main content
TipRanks
Go Ultimate75% OFF

Feng Chi Biotech Corp. (6744) Financial Statements

Feng Chi Biotech Corp. Financial Overview

Feng Chi Biotech Corp.'s market cap is currently NT$189.50M. The company's EPS TTM is NT$0.65; its P/E ratio is 19.54; and it has a dividend yield of 6.51%. Feng Chi Biotech Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 177.36MNT$ 171.10MNT$ 180.58MNT$ 193.46MNT$ 182.57M
Gross ProfitNT$ 79.16MNT$ 77.15MNT$ 79.60MNT$ 83.44MNT$ 86.11M
Operating IncomeNT$ 13.85MNT$ 16.12MNT$ 24.16MNT$ 27.07MNT$ 26.44M
EBITDANT$ 25.97MNT$ 29.80MNT$ 34.84MNT$ 36.79MNT$ 36.96M
Net IncomeNT$ 14.47MNT$ 16.59MNT$ 22.79MNT$ 24.61MNT$ 23.14M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 178.63MNT$ 207.68MNT$ 216.44MNT$ 235.41MNT$ 230.78M
Total AssetsNT$ 287.91MNT$ 299.07MNT$ 301.03MNT$ 308.36MNT$ 286.69M
Total DebtNT$ 5.43MNT$ 8.15MNT$ 10.80MNT$ 13.48MNT$ 2.55M
Net DebtNT$ -11.96MNT$ -18.10MNT$ -19.81MNT$ -52.42MNT$ -46.26M
Total LiabilitiesNT$ 48.01MNT$ 59.19MNT$ 63.03MNT$ 72.49MNT$ 56.18M
Stockholders' EquityNT$ 239.90MNT$ 239.88MNT$ 238.00MNT$ 235.87MNT$ 230.51M
Cash Flow
Free Cash FlowNT$ -9.89MNT$ 10.46MNT$ 14.02MNT$ 28.23MNT$ 31.83M
Operating Cash FlowNT$ 3.24MNT$ 25.05MNT$ 15.41MNT$ 28.49MNT$ 32.92M
Investing Cash FlowNT$ 5.26MNT$ -10.60MNT$ -27.34MNT$ 10.62MNT$ -10.97M
Financing Cash FlowNT$ -17.35MNT$ -18.82MNT$ -23.37MNT$ -22.01MNT$ -20.42M

Currency in TWD

Feng Chi Biotech Corp. Earnings and Revenue History

080M160M240M7.5 %10 %12.5 %15 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Feng Chi Biotech Corp. Liabilities to Assets

0120M240M360M15 %20 %25 %30 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Feng Chi Biotech Corp. Cash Flow

-100M-75M-50M-25M025M50M201720182019202020212022202320242025OperatingInvestingFinancing

Feng Chi Biotech Corp. Forecast EPS vs Actual EPS